Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ANROthis companyAlto Neuroscience, Inc.	$27.89	-8.13×	3.4×	0×	-5.68×	-73.1%	0.0%	0.0%	0.0%	-41.8%	-38.2%	-10.1%	0.03×	2.86×	-26.88×	15.69×	0.0%	2	13.38	2	C+
ALDXAldeyra The	$0.65	-9.25×	7.03×	0×	-8.1×	55.2%	0.0%	0.0%	0.0%	-76.5%	-59.0%	-10.7%	0.35×	1.72×	-18.51×	2.58×	0.0%	2	-12.88	2	B-
CTNMContineum Therapeutics, Inc.	$10.00	-5.27×	1.21×	0×	-3.68×	-74.9%	0.0%	0.0%	0.0%	-23.0%	-25.3%	-17.5%	0.03×	0.99×	0×	27.5×	0.0%	2	16.76	2	C+
KRROKorro Bio, Inc.	$15.22	-0.64×	1.46×	11.77×	-1.17×	-42.0%	33.0%	-1366.4%	-1834.5%	-228.0%	-83.8%	-105.1%	0.85×	-0.26×	0×	6.9×	0.0%	2	-1.99	1	C-
LRMRLarimar Therapeutics, Inc.	$2.48	-1.68×	3.56×	0×	-1.19×	-55.3%	0.0%	0.0%	0.0%	-212.2%	-210.0%	-40.8%	0.05×	0.49×	0×	2.19×	0.0%	1	-2.84	2	C+
Peer median	—	-3.47×	2.51×	0×	-2.43×	-48.7%	0.0%	0.0%	0.0%	-144.3%	-71.4%	-29.2%	0.2×	0.74×	0×	4.74×	0.0%	2	-2.42	2	—